Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
46.15
-0.08 (-0.17%)
At close: Aug 13, 2025, 4:00 PM
45.75
-0.40 (-0.87%)
After-hours: Aug 13, 2025, 7:56 PM EDT
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $5.94 billion as of August 13, 2025. Its market cap has increased by 20.43% in one year.
Market Cap
5.94B
Enterprise Value
4.76B
1-Year Change
20.43%
Ranking
Category
Stock Price
$46.15
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $5.94B, an increase of 489.32%. That is a compound annual growth rate of 40.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 5.94B | 71.20% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 577.46B |
| Johnson & Johnson | 418.74B |
| AbbVie | 348.10B |
| UnitedHealth Group | 231.41B |
| Abbott Laboratories | 228.93B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |